檢索結果 - David C. Fajgenbaum
- Showing 1 - 20 results of 28
- Go to Next Page
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
Predictors of response to anti‐<scp>IL</scp>6 monoclonal antibody therapy (siltuximab) in idiopathic multicentric Castleman disease: secondary analyses of phase<scp>II</scp>clinica... 由 Deanna E. Morra, Sheila K. Pierson, Dustin Shilling, Sepideh Nemat, Carlos Appiani, Mary Guilfoyle, Craig Tendler, Frits van Rhee, David C. Fajgenbaum
出版 2018Artigo -
12
-
13
The involvement of PI3K–Akt signaling in the clinical and pathologic findings of iMCD-TAFRO and NOS subtypes. 由 Tomoka Haratake, Midori Filiz Nishimura, Asami Nishikori, Michael V. Gonzalez, Daisuke Ennishi, Ying‐Chieh Lai, Satoshi Ochi, Masatoshi Tsunoda, David C. Fajgenbaum, Frits van Rhee, Shuji Momose, Yasuharu Sato
出版 2025Artigo -
14
Longitudinal, natural history study reveals the disease burden of idiopathic multicentric Castleman disease 由 Mateo Sarmiento Bustamante, Sheila K. Pierson, Yue Ren, Adam Bagg, Joshua D. Brandstadter, Gordan Srkalović, Natalie Mango, Daisy Alapat, Mary Jo Lechowicz, Hongzhe Li, Frits van Rhee, Megan S. Lim, David C. Fajgenbaum
出版 2024Artigo -
15
Validated international definition of the thrombocytopenia, anasarca, fever, reticulin fibrosis, renal insufficiency, and organomegaly clinical subtype (TAFRO) of idiopathic multic... 由 Yoshito Nishimura, David C. Fajgenbaum, Sheila K. Pierson, Noriko Iwaki, Asami Nishikori, Mitsuhiro Kawano, Naoya Nakamura, Koji Izutsu, Kengo Takeuchi, Midori Filiz Nishimura, Yoshinobu Maeda, Fumio Otsuka, Kazuyuki Yoshizaki, Éric Oksenhendler, Frits van Rhee, Yasuharu Sato
出版 2021Artigo -
16
Clinical and pathological characteristics of HIV- and HHV-8–negative Castleman disease 由 Yu Li, Meifeng Tu, Jorge E. Cortés, Zijun Y. Xu‐Monette, Roberto N. Miranda, Jun Zhang, Robert Z. Orlowski, Sattva S. Neelapu, Prajwal Boddu, Mary Akosile, Thomas S. Uldrick, Robert Yarchoan, L. Jeffrey Medeiros, Yong Li, David C. Fajgenbaum, Ken H. Young
出版 2017Artigo -
17
Type I IFN response associated with mTOR activation in the TAFRO subtype of idiopathic multicentric Castleman disease 由 Ruth-Anne Langan Pai, Alberto Sada Japp, Michael V. Gonzalez, Rozena Rasheed, Mariko Okumura, Daniel Arenas, Sheila K. Pierson, Victoria Powers, Awo Akosua Kesewa Layman, Charlly Kao, Hákon Hákonarson, Frits van Rhee, Michael R. Betts, Taku Kambayashi, David C. Fajgenbaum
出版 2020Artigo -
18
Exploring the Clinical Diversity of Castleman Disease and <scp>TAFRO</scp> Syndrome: A Japanese Multicenter Study on Lymph Node Distribution Patterns 由 Mizuna Otsuka, Tomohiro Koga, Remi Sumiyoshi, Shoichi Fukui, Yuko Kaneko, Takayuki Shimizu, Atsushi Katsube, Shingo Yano, Yasufumi Masaki, Makoto Ide, Hajime Yoshifuji, Masayasu Kitano, Yasuharu Sato, Naoki Sawa, Hiroaki Niiro, Naoya Nakamura, David C. Fajgenbaum, Frits van Rhee, Atsushi Kawakami
出版 2025Artigo -
19
Increased mTOR activation in idiopathic multicentric Castleman disease 由 Daniel J. Arenas, Katherine Floess, Dale Kobrin, Ruth-Anne Langan Pai, Maya Blanka Srkalovic, Mark-Avery Tamakloe, Rozena Rasheed, Jasira Ziglar, Johnson S. Khor, Sophia A. T. Parente, Sheila K. Pierson, Daniel Martínez, Gerald Wertheim, Taku Kambayashi, Joseph A. Baur, David T. Teachey, David C. Fajgenbaum
出版 2020Artigo -
20
Clinicopathologic analysis of <scp>TAFRO</scp> syndrome demonstrates a distinct subtype of <scp>HHV</scp>‐8‐negative multicentric Castleman disease 由 Noriko Iwaki, David C. Fajgenbaum, Christopher S. Nabel, Yuka Gion, Eisei Kondo, Mitsuhiro Kawano, Taro Masunari, Isao Yoshida, Hiroshi Moro, Koji Nikkuni, Kazue Takai, Kosei Matsue, Mitsutoshi Kurosawa, Masao Hagihara, Akio Saito, Masataka Okamoto, Kenji Yokota, Shinichiro Hiraiwa, Naoya Nakamura, Shinji Nakao, Tadashi Yoshino, Yasuharu Sato
出版 2015Artigo
相關主題
Medicine
Internal medicine
Disease
Immunology
Castleman disease
Pathology
Gastroenterology
Organomegaly
Lymph node
Anasarca
Biology
Cytokine
Coronavirus disease 2019 (COVID-19)
Infectious disease (medical specialty)
Lymphoma
Pathogenesis
Asymptomatic
Cytokine storm
Human immunodeficiency virus (HIV)
Inflammation
Oncology
Polyneuropathy
Rituximab
Signal transduction
Antibody
B cell
Bone marrow
Cancer research
Cell biology
Clinical trial